Answers are grounded in this paper and cite their sources.
Due to the significant role of clinical biomolecules in mediating biological activities and disease progressions, in situ analysis provides a great opportunity for understanding the molecular mechanisms of biological functions, facilitating medical diagnosis, clinical treatment, and prognosis. Among all the analysis methods, mass spectrometry (MS) methodologies exhibit unique features that make them exceptionally suitable for clinical tests. In this review, updated and essential developments of MS technologies, including laser‐based, spray‐based, plasma‐based, and intrasurgical MS techniques for clinical analysis are summarized. Moreover, further perspectives including design of portable sampling devices, introduction of miniature MS instrumentation, development of high‐throughput and multiplexed methodologies for clinical routine tests and point‐of‐care tests are proposed to achieve better advancements and practical applications of clinical MS.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: